Cargando…
Clinical Trial Registration and Reporting: Drug Therapy and Prevention of Cardiac-Related Infections
Objective: Clinical trials are the source of evidence. ClinicalTrials.gov is valuable for analyzing current conditions. Until now, the state of drug interventions for heart infections is unknown. The purpose of this study was to comprehensively assess the characteristics of trials on cardiac-related...
Autores principales: | Ma, Lin-Lu, Qiu, Yang, Song, Mei-Na, Chen, Yun, Qu, Jian-Xin, Li, Bing-Hui, Zhao, Ming-Juan, Liu, Xin-Can |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6624234/ https://www.ncbi.nlm.nih.gov/pubmed/31333470 http://dx.doi.org/10.3389/fphar.2019.00757 |
Ejemplares similares
-
Analysis of Suspension of Clinical Trials for Drug Registration in China
por: Su, Xian, et al.
Publicado: (2021) -
Comprehensive Survey of Clinical Trials Registration for Melanoma Immunotherapy in the ClinicalTrials.gov
por: Wang, Yan-Bo, et al.
Publicado: (2020) -
Therapeutic Drug Monitoring of Ceftazidime-Avibactam Concentrations in Carbapenem-Resistant K. pneumoniae-Infected Patients With Different Kidney Statuses
por: Teng, Xin-Qi, et al.
Publicado: (2022) -
Selective Inhibition of the Immunoproteasome β5i Prevents PTEN Degradation and Attenuates Cardiac Hypertrophy
por: Xie, Xin, et al.
Publicado: (2020) -
Medical image registration utilizing tissue P systems
por: Kujur, Saleem Sanatan, et al.
Publicado: (2022)